Average PSA levels in current, regular (“nearly every day”) users of NSAIDs (19.8% of the study population) were 10% lower than those of patients who were not taking any of the drugs of ...
Several types of medication can effectively treat PsA symptoms. Certain over-the-counter (OTC) medications, such as ibuprofen, may help reduce symptoms. If OTC drugs don’t reduce your joint pain ...
The Drug-Free Council of Alto High School recently traveled to two area radio stations to record public service announcements ...
12 小时
MyChesCo on MSNJohnson & Johnson’s TREMFYA Demonstrates Significant Benefits in Psoriatic Arthritis StudyHOUSE, PA — Johnson & Johnson has announced promising results from its Phase 3b APEX trial for TREMFYA® (guselkumab), ...
Secukinumab treatment reduces bone erosion volume and enhances partial healing of erosions in patients with psoriatic ...
Johnson & Johnson (JNJ) reports a Phase 3 success for its anti-inflammatory drug Tremfya in treating psoriatic arthritis.
The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.
Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs have transformed the way we think about our bodies, weight loss, and wellness. The first time Heather’s doctor suggested ...
Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.
STEQEYMA is available in both subcutaneous injection and intravenous infusion and is indicated for the treatment of plaque psoriasis (PsO) and psoriatic arthritis (PsA) in adult and pediatric patients ...
Telix’s next-generation PSMA-PET imaging agent for prostate cancer, Gozellix receives US FDA approves: Melbourne, Australia Monday, March 24, 2025, 17:00 Hrs [IST] Telix, a biop ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果